F-group (family)
101.1.1.30 Sigma70_r3,Sigma70_r4
Ligands and drugs
266
Member domains
25
with ligand contacts (≤ 4 Å)
9.4% of members
28
with DrugDomain annotations
10.5% of members
10
with a DrugBank compound
3.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 101.1.1.30 belongs to X-group 101 HTH, which binds 8.7 ligand superclasses per 20 proteins, broader than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01045 | RFP | Rifampin | 4 |
| DB08874 | FI8 | Fidaxomicin | 4 |
| DB00142 | GLU | Glutamic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| 1N7 | CHAPSO | 7 |
| FI8 | Fidaxomicin | 4 |
| RFP | RIFAMPICIN | 4 |
| SF4 | IRON/SULFUR CLUSTER | 2 |
| SRN | SORANGICIN A | 2 |
| KNG | Kanglemycin A | 1 |
| KYO | (9S,14S,15R,16S,17R,18R,19R,20S,21S,25R)-5,6,18,20-tetrahydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-10,26-dioxo-1,3,9,10-tetrahydrospiro[9,4-(epoxypentadecanoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin]-16-yl benzoate | 1 |